Navigation Links
Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis
Date:11/23/2009

erm outcomes for cystinosis patients; and that any of Raptor's clinical and preclinical drug candidates will result in approved therapeutics. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, which may cause the Company's actual results to be materially different from these forward-looking statements. Factors which may significantly change or prevent the Company's forward looking statements from fruition include: that Raptor may be unsuccessful at raising funds to continue its development programs; Raptor may be unsuccessful in developing any products or acquiring products; that Raptor's technology may not be validated as it progresses further and its methods may not be accepted by the scientific community; that Raptor is unable to retain or attract key employees whose knowledge is essential to the development of its products; that unforeseen scientific difficulties develop with the Company's process; that Raptor's patents are not sufficient to protect essential aspects of its technology; that competitors may invent better technology; and that Raptor's products may not work as well as hoped or worse, that the Company's products may harm recipients. As well, Raptor's products may never develop into useful products and even if they do, they may not be approved for sale to the public. Raptor cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date they were made. Certain of these risks, uncertainties, and other factors are described in greater detail in the Company's filings from time to time with the Securities and Exchange Commission (the "SEC"), which Raptor strongly urges you to read and consider, including Raptor's current report on Form 8-K as filed with the SEC on November 17, 2009; the joint proxy statement/prospectus on Form S-4 filed with the SEC on August 19, 2009; Raptor's annual report on Form 10-K filed with the SEC on March 27, 2009; an
'/>"/>
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference
2. Merriman Curhan Ford Acted as Financial Advisor to TorreyPines Therapeutics, Inc. in the Completed Merger With Raptor Pharmaceuticals Corp.
3. Raptor Pharmaceutical Expands Board of Directors
4. Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
5. Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications
6. Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
7. Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
8. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
9. Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire dAngers for Phase II Clinical Trial in Huntingtons Disease
10. Raptor Pharmaceuticals Provides Update on Targeting Platforms
11. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015 /PRNewswire/ ... MXIM ) makes it easy to ... to monitor or control unsanitary reuse ... gamma-radiation-resistant, nonvolatile (NV) 1-Wire® memory. ... http://www.maximintegrated.com/en/products/digital/memory-products/DS28E80.html , Maxim,s ...
(Date:5/27/2015)... -- Foundation Health Care  (FDNH), which owns and operates hospitals ... it will present at the LD Micro Invitational Conference ... Boulevard Hotel, Los Angeles, CA. ... at 3:00pm and will also be available for ... LD Micro. For more information about the conference, please ...
(Date:5/27/2015)... Calif. , May 27, 2015  Abaxis, Inc. ... point-of-care blood analysis systems, announced today that Ross ... relations, transitioning into the role of chief financial officer ... 2015 Global Healthcare Conference on Thursday, June 4, 2015 ... at the Grand Hyatt in New York ...
Breaking Medicine Technology:Gamma-Radiation-Resistant Memory Provides Calibration and Protects from Unsanitary Reuse in Medical Disposables 2Gamma-Radiation-Resistant Memory Provides Calibration and Protects from Unsanitary Reuse in Medical Disposables 3
... Actavis Group, an international generic pharmaceuticals company, today announced ... & Drug Administration to market Valacyclovir Hydrochloride Tablets.   ... gram, the generic equivalent of Valtrex® by GlaxoSmithKline, had ... months ending December 31, 2010, according to IMS Health. ...
... Air Products (NYSE: APD ) announced today ... Imaging, Inc., one of the United States, largest independent ... Illinois. Under the agreement, Air Products will supply its ... currently installed by Genesis for MRI scans at medical ...
Cached Medicine Technology:Actavis Receives Approval of Valacyclovir Hydrochloride Tablets in the U.S. 2Air Products Lands Contract with Genesis for KeepCOLD® Cryogenic Services 2Air Products Lands Contract with Genesis for KeepCOLD® Cryogenic Services 3
(Date:5/27/2015)... New York, NY (PRWEB) May 27, 2015 ... excellence, has launched in the U.S. with its first ... products are available for purchase nationwide through http://www.difassusa.com ... to a person’s health and productivity, but some people ... need each night. Dormiva™ is a sleep aid designed ...
(Date:5/27/2015)... 27, 2015 Cincinnati Veterans Affairs Women’s Health ... Veterans (CERV) Foundation is proud to host the first annual ... Veterans June 11 at the Freedom Center from 6 p.m. ... be the emcee. , This event honors and celebrates ... nation. The banquet is free to the first 150 ...
(Date:5/27/2015)... With InnerVoice Communication App you will ... is not only heard but seen -- by a photograph ... image. This award-winning and affordable app takes full advantage of ... InnerVoice Sender app in conjunction with InnerVoice Communication ... remotely for no additional cost. , InnerVoice Sender ...
(Date:5/27/2015)... May 27, 2015 SmarterSkin, http://www.smarterskindermatology.com , ... a cutting-edge test that makes it easier for patients to ... type. , Dr. Sejal Shah is a cosmetic dermatologist ... NYC to offer the test. This revolutionary DNA test uses ... with skin aging: , 1. Firmness and elasticity ...
(Date:5/27/2015)... Splashtop Inc., the worldwide leader in cross-device computing and ... extended display product line -- the Mirroring360 Sender ... room, users can instantly stream their Windows PC or tablet ... Apple TV, a computer, or a range of media devices ... the Google Nexus Player. , The Mirroring360 Sender ...
Breaking Medicine News(10 mins):Health News:Supplement Brand Difass USA Launches in the U.S. with Three Flagship Products Designed to Bring Balance Back to Your Life 2Health News:Cincinnati VA Women’s Health Clinic Celebrates Women Veterans at Awards Banquet 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 3Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 4Health News:SmarterSkin Dermatology is Now Offering Skin DNA Analysis 2Health News:Splashtop Launches the Fastest Computer Screen Mirroring and Extended Display Solution – to Apple TV and other Smart Displays 2Health News:Splashtop Launches the Fastest Computer Screen Mirroring and Extended Display Solution – to Apple TV and other Smart Displays 3
... the most dreadful kind of Dementia, where there is degeneration ... awaited miracle cure round the corner. A vaccine made ... in mice, which is characteristic of Alzheimer’s. Latest reports say ... human testing ,the first stages of which have been successful ...
... loved one die. More tragic is when the decision on ... thread. Most patients of road traffic accidents, severe stokes, head ... where they live technically only on life support systems. The ... to give consent to the medical staff attending on these ...
... open show of support to Alternative Medicine, Britain's Prince Charles ... million) to fund a five-year research program into the effects ... taking notice of holistic medicine and Prince Charles’s support to ... in the arm for these crusaders of integrated medicine. ...
... word to make people sit up and take notice in health ... mention of the word is enough to bolster people to sit ... heard and said about the disease? Or should we use our ... Should we believe all that is written about and said about ...
... the dosages of drugs are determined? How drugs are being ... What happens if the dosages are unwittingly missed? Or worse ... happens? Who answers these questions? In a shocking revelation, ... instances about a third of medication errors that result in ...
... supplements have been identified as having a possible ... so by reducing the level of an amino acid called ... the culprit, increasing clot formation in blood vessels. ,Ongoing ... about the superior benefits of these vitamin supplements over a ...
Cached Medicine News:Health News:Brain death – How to cope with it 2Health News:The Cancer Rumour mill working over time 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: